Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Interventional × Dactinomycin × Clear all

Phase

Phase 3 22 Phase 2 17 Phase NA 2 Phase 1/2 2 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Ewing 1

Interventions

Cyclophosphamide 558 pembrolizumab 433 Paclitaxel 397 Gemcitabine 382 Cisplatin 379 Carboplatin 374 Radiotherapy 335 fludarabine 318 Nivolumab 298 Bevacizumab 245 Docetaxel 241 Irinotecan 218 Magnetic Resonance Spectroscopy 213 Dexamethasone 200 Fluorouracil 197 Specimen Handling 194 Capecitabine 191 Rituximab 181 Cytarabine 181 fludarabine phosphate 174 Oxaliplatin 173 Biopsy 171 Temozolomide 170 Ipilimumab 166 Lenalidomide 162 Etoposide 161 Doxorubicin 152 Cetuximab 151 Leucovorin 148 Bortezomib 147

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07194044 2026-03-16

METTSEO

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡